ArticleCancer management and research2020

A New Immunological Prognostic Model Based on Immunohistochemistry for Extranodal Natural Killer/T-Cell Lymphoma Patients After Non-Anthracycline-Based Chemotherapy.

Sio Teng Lam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.